Author response: Comprehensive systematic review summary: Disease-modifying therapies for adults with multiple sclerosis: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology

Affiliations

Comment

Alex D Rae-Grant. Neurology. 2019.

. 2019 Oct 22;93(17):765.

doi: 10.1212/WNL.0000000000008376.

No abstract available

Comment on

Comprehensive systematic review summary: Disease-modifying therapies for adults with multiple sclerosis: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.
Rae-Grant A, Day GS, Marrie RA, Rabinstein A, Cree BAC, Gronseth GS, Haboubi M, Halper J, Hosey JP, Jones DE, Lisak R, Pelletier D, Potrebic S, Sitcov C, Sommers R, Stachowiak J, Getchius TSD, Merillat SA, Pringsheim T. Rae-Grant A, et al. Neurology. 2018 Apr 24;90(17):789-800. doi: 10.1212/WNL.0000000000005345. Neurology. 2018. PMID: 29686117 Review.
Reader response: Comprehensive systematic review summary: Disease-modifying therapies for adults with multiple sclerosis: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.
Tran KR. Tran KR. Neurology. 2019 Oct 22;93(17):764-765. doi: 10.1212/WNL.0000000000008366. Neurology. 2019. PMID: 31636227 No abstract available.